Phase III prospective randomized comparison trial of depot octreotide plus interferon alfa-2b versus depot octreotide plus bevacizumab in patients with advanced carcinoid tumors: SWOG S0518 - Yao, J C; Guthrie, K A; Moran, C (J Clin Oncol, 2017)
, et al.